Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Int Wound J ; 21(3): e14808, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38425135

ABSTRACT

We evaluated the primary application of crushed prednisolone combined with hydrocolloid powder for clinically diagnosed peristomal pyoderma gangrenosum (PPG). We present our data on this cohort and follow-up of our previous patients. Of the 23 patients who were commenced on this regime, 18 healed (78%). Twenty-two patients commenced on this regime as the primary treatment for their PPG, and for one, it was a rescue remedy after failed conventional therapy. Four patients with significant medical comorbidities failed to heal and one had their stomal reversal surgery before being fully healed. The proposed treatment regime for PPG is demonstrated to be effective, inexpensive and able to be managed in the patient's usual home environment. In vitro drug release analysis was undertaken, and data are presented to provide further insights into the efficacy of this regime.


Subject(s)
Prednisolone , Pyoderma Gangrenosum , Humans , Prednisolone/therapeutic use , Pyoderma Gangrenosum/drug therapy , Pyoderma Gangrenosum/etiology , Pyoderma Gangrenosum/diagnosis , Powders/therapeutic use , Drug Liberation , Treatment Outcome
2.
Adv Skin Wound Care ; 34(7): 1-6, 2021 Jul 01.
Article in English | MEDLINE | ID: mdl-33851936

ABSTRACT

ABSTRACT: Vascular Ehlers-Danlos syndrome (EDSv) can present with life-threatening surgical complications. The article describes the case of a patient with EDSv who developed total abdominal wound dehiscence and multiple enterocutaneous fistulas. Treatment with IV allogeneic mesenchymal stromal cells (MSCs) and high-dose vitamin C was trialed with success. Near-complete wound healing of the abdominal dehiscence with a 94% reduction in the size of the wound bed occurred. Maturation of the enterocutaneous fistulas also ensued.There is no current consensus on the management of large cutaneous wounds in EDSv. This article discusses the pathophysiology of wound healing with regard to nutrition requirements and growth factors with special reference to collagen deficits in EDSv. A potential therapy with IV vitamin C supplementation and MSCs is proposed following the patient's positive outcome. Medium-dose MSCs and high-dose IV vitamin C may offer significant benefits to complex and problematic wounds.


Subject(s)
Ascorbic Acid/therapeutic use , Ehlers-Danlos Syndrome/complications , Mesenchymal Stem Cells , Wound Healing/drug effects , Abdomen/physiopathology , Adult , Collagen/drug effects , Collagen/metabolism , Ehlers-Danlos Syndrome/physiopathology , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL